| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
3 companies
Parker Geoffrey M. is a Chief Financial Officer at ALLO, with reported holdings spanning 3 companies. Recent filings cover 15 purchases and 4 sales. Those positions are worth an estimated $2.1M at current prices.
Our model assigns Parker Geoffrey M. a below-average insider score of 46/100, based on 11 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -24.5%.
Parker Geoffrey M.'s largest disclosed position is in ALLO as Chief Financial Officer, worth about $1.4M. The recent filings there lean toward selling, a net 101,258 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 36,342 | $1.34 | $48,698.28 | -3.4% | - | - | |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 24,001 | $1.76 | $42,241.76 | -1.9% | +20.9% | - | |
| Nov 12, 2025 | PRGO Perrigo Co Plc | Director | Buy | 7,500 | $14.18 | $106,350.00 | +75.9% | +1.6% | - | |
| Oct 21, 2025 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 36,744 | $1.26 | $46,168.84 | -2.8% | +24.6% | +5.6% | |
| Aug 18, 2025 | PRGO Perrigo Co Plc | Director | Buy | 4,375 | $22.97 | $100,497.25 | +15.1% | -41.1% | -43.7% | |
| May 12, 2025 | PRGO Perrigo Co Plc | Director | Buy | 3,500 | $27.10 | $94,850.00 | +17.3% | -18.4% | -58.8% | |
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Sell | 4,361 | $1.73 | $7,544.53 | -0.3% | -3.0% | +4.2% | |
| Jan 30, 2024 | ALLO Allogene Therapeutics, Inc. | Chief Financial Officer | Buy | 190 | $3.60 | $683.05 | - | -21.1% | -48.9% | |
| Jun 13, 2023 | PRGO Perrigo Co Plc | Director | Buy | 10,000 | $33.06 | $330,637.00 | +63.0% | +3.1% | -15.9% | |
| Mar 6, 2023 | PRGO Perrigo Co Plc | Director | Buy | 5,000 | $38.05 | $190,270.00 | +46.0% | -10.6% | -26.2% |